Skip to main content
. 2017 Mar 27;114(15):3999–4004. doi: 10.1073/pnas.1616874114

Fig. S1.

Fig. S1.

Pharmacokinetics of XCT0135908. Intraperitoneal administration of XCT0135908 in mice (1 mg/kg) resulted in minimal penetration of the compound in the brain. Three serial tail bleeds were performed to detect the compound in plasma at 1 and 2 h after i.p. administration. Similarly, mice (n = 3) were killed at 1 and 2 h after i.p. administration, and brains were dissected. The concentrations of the parent compound in plasma and brain were determined by LC-MS/MS.